Renal damage by monoclonal immunoglobulin and/ or free light chains Classification according to the „International Kidney and Monoclonal Gammopathy Research Group“
Authors:
Z. Adam 1; M. Kment 2; T. Roháľ 3; J. Řehořová 4; M. Krejčí 1; Z. Král 1; L. Pour 1
Authors‘ workplace:
Interní hematologická a onkologická klinika LF MU a FN Brno
1; Institut klinické a experimentální medicíny, Pracoviště klinické a transplantační patologie, Praha
2; Institut klinické a experimentální medicíny (IKEM), Klinika nefrologie, Praha
3; Interní gastroenterologická klinika LF MU a FN Brno
4
Published in:
Transfuze Hematol. dnes,31, 2025, No. Ahead of Print, p. 1-10.
Category:
Review/Educational Papers
doi:
https://doi.org/10.48095/cctahd2025prolekare.cz7
Labels
Haematology Internal medicine Clinical oncologyArticle was published in
Transfusion and Haematology Today
2025 Issue Ahead of Print
- Cost Effectiveness of FVIII Substitution Versus Non-Factor Therapy for Hemophilia A
- Vascular Disease in the Gradually Aging Population of Hemophiliacs: An Underestimated Problem?
- Prognostic Significance of Subclinical Joint Changes on MRI in Hemophilia
- Immunotolerance is still the goal of management of hemophilia A with inhibitor in the era of non-factor therapy
- Minimum and Optimal Factor Levels in Physically Active Hemophiliacs
Most read in this issue
- Interdisciplinary recommendations for thrombophilia testing
- Cardiovascular complications in multiple myeloma
- Trends in allogeneic haematopoietic cell transplantation – analysis of the activity of the transplant centre at the University Hospital Plzeň in the period 2001– 2021
- Renal damage by monoclonal immunoglobulin and/ or free light chains Classification according to the „International Kidney and Monoclonal Gammopathy Research Group“